PortalPublikationenEUSICA/COST IMMUNO-model workshop fostering collaboration to...

EUSICA/COST IMMUNO-model workshop fostering collaboration to advance sinonasal cancer research: A meeting report

Standard

EUSICA/COST IMMUNO-model workshop fostering collaboration to advance sinonasal cancer research: A meeting report. / Hermsen, Mario A; Lechner, Matt; Oliveira Ferrer, Leticia; Trama, Annalisa; Eriksen, Patrick René Gerhard; Martinez-Balibrea, Eva; von Buchwald, Christian.

in: ORAL ONCOL, Jahrgang 146, 11.2023, S. 106543.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Kommentar › Forschung

Harvard

Hermsen, MA, Lechner, M, Oliveira Ferrer, L, Trama, A, Eriksen, PRG, Martinez-Balibrea, E & von Buchwald, C 2023, 'EUSICA/COST IMMUNO-model workshop fostering collaboration to advance sinonasal cancer research: A meeting report', ORAL ONCOL, Jg. 146, S. 106543. https://doi.org/10.1016/j.oraloncology.2023.106543

APA

Hermsen, M. A., Lechner, M., Oliveira Ferrer, L., Trama, A., Eriksen, P. R. G., Martinez-Balibrea, E., & von Buchwald, C. (2023). EUSICA/COST IMMUNO-model workshop fostering collaboration to advance sinonasal cancer research: A meeting report. ORAL ONCOL, 146, 106543. https://doi.org/10.1016/j.oraloncology.2023.106543

Vancouver

Hermsen MA, Lechner M, Oliveira Ferrer L, Trama A, Eriksen PRG, Martinez-Balibrea E et al. EUSICA/COST IMMUNO-model workshop fostering collaboration to advance sinonasal cancer research: A meeting report. ORAL ONCOL. 2023 Nov;146:106543. https://doi.org/10.1016/j.oraloncology.2023.106543

Bibtex

@article{b55f587cd17c4d4c95258adf456521be,
title = "EUSICA/COST IMMUNO-model workshop fostering collaboration to advance sinonasal cancer research: A meeting report",
abstract = "Sinonasal cancer is a clinically and histologically heterogeneous group of rare tumors with generally poor clinical outcomes. Their low incidence hampers the advancement of clinical management as well as translational research, and calls for multicenter and multinational collaboration between physicians and researchers. This report describes the proceedings of a two-day conference organized by the European Network for Sinonasal Cancer Research (EUSICA) and COST Action 'IMMUNO-model', fostering such collaboration and focusing on preclinical tumor and immuno models, surgical and radio-oncological treatments, core facilities for genetic characterization and molecular tumor classification, and cancer registry.",
keywords = "Humans, Paranasal Sinus Neoplasms/therapy, Registries",
author = "Hermsen, {Mario A} and Matt Lechner and {Oliveira Ferrer}, Leticia and Annalisa Trama and Eriksen, {Patrick Ren{\'e} Gerhard} and Eva Martinez-Balibrea and {von Buchwald}, Christian",
note = "Copyright {\textcopyright} 2023 Elsevier Ltd. All rights reserved.",
year = "2023",
month = nov,
doi = "10.1016/j.oraloncology.2023.106543",
language = "English",
volume = "146",
pages = "106543",
journal = "ORAL ONCOL",
issn = "1368-8375",
publisher = "Elsevier Limited",

}

RIS

TY - JOUR

T1 - EUSICA/COST IMMUNO-model workshop fostering collaboration to advance sinonasal cancer research: A meeting report

AU - Hermsen, Mario A

AU - Lechner, Matt

AU - Oliveira Ferrer, Leticia

AU - Trama, Annalisa

AU - Eriksen, Patrick René Gerhard

AU - Martinez-Balibrea, Eva

AU - von Buchwald, Christian

N1 - Copyright © 2023 Elsevier Ltd. All rights reserved.

PY - 2023/11

Y1 - 2023/11

N2 - Sinonasal cancer is a clinically and histologically heterogeneous group of rare tumors with generally poor clinical outcomes. Their low incidence hampers the advancement of clinical management as well as translational research, and calls for multicenter and multinational collaboration between physicians and researchers. This report describes the proceedings of a two-day conference organized by the European Network for Sinonasal Cancer Research (EUSICA) and COST Action 'IMMUNO-model', fostering such collaboration and focusing on preclinical tumor and immuno models, surgical and radio-oncological treatments, core facilities for genetic characterization and molecular tumor classification, and cancer registry.

AB - Sinonasal cancer is a clinically and histologically heterogeneous group of rare tumors with generally poor clinical outcomes. Their low incidence hampers the advancement of clinical management as well as translational research, and calls for multicenter and multinational collaboration between physicians and researchers. This report describes the proceedings of a two-day conference organized by the European Network for Sinonasal Cancer Research (EUSICA) and COST Action 'IMMUNO-model', fostering such collaboration and focusing on preclinical tumor and immuno models, surgical and radio-oncological treatments, core facilities for genetic characterization and molecular tumor classification, and cancer registry.

KW - Humans

KW - Paranasal Sinus Neoplasms/therapy

KW - Registries

U2 - 10.1016/j.oraloncology.2023.106543

DO - 10.1016/j.oraloncology.2023.106543

M3 - Comment/debate

C2 - 37573683

VL - 146

SP - 106543

JO - ORAL ONCOL

JF - ORAL ONCOL

SN - 1368-8375

ER -